Article info

Download PDFPDF

Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Authors

  1. a Asim.Amin{at}carolinashealthcare.org
View Full Text

Citation

Amin A, Plimack ER, Ernstoff MS, et al
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Publication history

  • Received March 8, 2019
  • Accepted March 8, 2019
  • First published March 14, 2019.
Online issue publication 
March 14, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.